zonisamide has been researched along with Bulimia in 2 studies
Zonisamide: A benzisoxazole and sulfonamide derivative that acts as a CALCIUM CHANNEL blocker. It is used primarily as an adjunctive antiepileptic agent for the treatment of PARTIAL SEIZURES, with or without secondary generalization.
zonisamide : A 1,2-benzoxazole compound having a sulfamoylmethyl substituent at the 3-position.
Bulimia: Eating an excess amount of food in a short period of time, as seen in the disorder of BULIMIA NERVOSA. It is caused by an abnormal craving for food, or insatiable hunger also known as ox hunger.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Compared with placebo, zonisamide was associated with a significantly greater rate of reduction in binge eating episode frequency (p = ." | 9.12 | Zonisamide in the treatment of binge eating disorder with obesity: a randomized controlled trial. ( D'Alessio, DA; Guerdjikova, AI; Hudson, JI; Keck, PE; Kotwal, R; Lake, KA; McElroy, SL; Nelson, EB; Welge, JA, 2006) |
| "Compared with placebo, zonisamide was associated with a significantly greater rate of reduction in binge eating episode frequency (p = ." | 5.12 | Zonisamide in the treatment of binge eating disorder with obesity: a randomized controlled trial. ( D'Alessio, DA; Guerdjikova, AI; Hudson, JI; Keck, PE; Kotwal, R; Lake, KA; McElroy, SL; Nelson, EB; Welge, JA, 2006) |
| "Zonisamide is a novel antiepileptic drug associated with weight loss." | 2.71 | Zonisamide in the treatment of binge-eating disorder: an open-label, prospective trial. ( Hudson, JI; Keck, PE; Kotwal, R; McElroy, SL; Nelson, EB, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| McElroy, SL | 2 |
| Kotwal, R | 2 |
| Hudson, JI | 2 |
| Nelson, EB | 2 |
| Keck, PE | 2 |
| Guerdjikova, AI | 1 |
| Welge, JA | 1 |
| Lake, KA | 1 |
| D'Alessio, DA | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Zonegran in the Treatment of Binge Eating Disorder Associated With Obesity: A Single Center, Double-Blind, Placebo-controlled, Flexible-Dose Study in Outpatients[NCT00221442] | Phase 3 | 60 participants (Actual) | Interventional | 2005-08-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 trials available for zonisamide and Bulimia
| Article | Year |
|---|---|
Zonisamide in the treatment of binge-eating disorder: an open-label, prospective trial.
Topics: Administration, Oral; Adult; Anticonvulsants; Body Weight; Bulimia; Female; Humans; Isoxazoles; Male | 2004 |
Zonisamide in the treatment of binge eating disorder with obesity: a randomized controlled trial.
Topics: Adult; Anticonvulsants; Body Mass Index; Bulimia; Dose-Response Relationship, Drug; Double-Blind Met | 2006 |